Key Takeaways
- Bernstein maintains Outperform rating with $641 price target for Microsoft (MSFT)
- Shares have plummeted 27.5% in six months, hovering near 52-week low at $370.87
- Analyst firm argues Azure margin compression is transient, linked to AI infrastructure investment timing
- Acceleration in Azure performance anticipated for Q3 with continued strength through Q4
- Consensus among Wall Street analysts remains Strong Buy with average target price of $581.61
Shares of Microsoft have endured significant pressure over the last half-year, tumbling 27.5% to reach $370.87. The stock is now hovering near its lowest point in 52 weeks. Yet Bernstein remains firmly optimistic about the company’s trajectory.
Mark Moerdler, analyst at Bernstein, has reaffirmed his Outperform rating alongside a $641 price objective for MSFT shares — representing potential upside exceeding 70% from current trading levels.
The crux of Bernstein’s thesis centers on timing dynamics. Microsoft has been investing heavily in artificial intelligence infrastructure, a strategy that has unsettled certain market participants. However, Moerdler contends the capital deployment isn’t as problematic as market sentiment suggests.
According to the firm’s analysis, the majority of this capital expenditure flows into capacity that begins producing revenue within a six-month timeframe after deployment. The temporal gap between outlay and return is creating an optical illusion that makes current financial metrics appear weaker than underlying fundamentals warrant.
Bernstein’s research evaluated five potential destinations for Microsoft’s capital expenditures: proprietary applications, complimentary Copilot access, internal operational use, Azure AI revenue streams with compressed margins, and infrastructure not yet operational. Their findings indicate a more advantageous allocation mix than market pricing reflects.
A substantial portion of investment is directed toward higher-margin segments, especially Microsoft’s proprietary software solutions and AI tooling. Copilot, specifically, is generating SaaS-characteristic AI revenue with healthy margins following the transition to subscription-based monetization.
Azure Profitability Facing Near-Term Headwinds — With Recovery Ahead
Azure’s profit margins have experienced compression, a reality Bernstein doesn’t dispute. The underlying cause, according to their analysis, stems from nascent AI workloads generating lower margins compared to established cloud service offerings.
As these workloads evolve and achieve scale, Bernstein projects margin profile improvement. The current pressure reflects Azure’s position within its AI growth trajectory rather than indicating fundamental structural challenges.
Research and development expenditure as a proportion of total revenue has remained essentially stable. Bernstein points to this metric as evidence that Microsoft maintains fiscal discipline despite aggressive AI investment.
Microsoft delivered 16.7% revenue expansion over the trailing twelve months. The equity currently trades at a P/E multiple of 23.26, with a PEG ratio of 0.8 — metrics that both Bernstein and InvestingPro characterize as undervalued relative to current price levels.
Azure Expansion Projected to Strengthen in Coming Quarters
Bernstein’s forecast calls for Azure growth rates to gain momentum during Q3, with sustained strength extending into Q4. This projection directly correlates with previously funded capacity becoming operational.
Microsoft is simultaneously pursuing a parallel initiative — creating proprietary large-scale AI models targeted for deployment by 2027 as alternatives to technologies from OpenAI and Anthropic.
UBS recently reaffirmed its Buy rating on Chevron following an energy generation partnership with Microsoft. The collaboration involves constructing natural gas power facilities in Texas dedicated to supplying electricity for Microsoft’s AI data center operations.
Examining broader Wall Street sentiment, 34 of 37 analysts who issued ratings on MSFT during the past three months assigned Buy recommendations. The consensus price target stands at $581.61, suggesting 56% appreciation potential from present levels.





